Upgrade to SI Premium - Free Trial

Abbvie (ABBV) PT Raised to $265 at Canaccord

April 30, 2026 6:35 AM
(Updated - April 30, 2026 6:59 AM EDT)

Canaccord analyst Gary Nachman raised the price target on Abbvie (NYSE ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change